Ocugen, Inc. (OCGN)
2.04
-0.20
(-8.93%)
USD |
NASDAQ |
Mar 20, 16:00
2.00
-0.04
(-1.96%)
After-Hours: 20:00
Ocugen Research and Development Expense (Quarterly) : 10.67M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| REGENXBIO, Inc. | 55.74M |
| Krystal Biotech, Inc. | 13.23M |
| MannKind Corp. | 27.59M |
| Altimmune, Inc. | 18.38M |
| EyePoint Plc | 59.21M |